Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Carcinoma, Non-Small-Cell Lung 214Lung Neoplasms 74Neoplasms 24Adenocarcinoma of Lung 16Neoplasm Metastasis 15Mesothelioma, Malignant 15Parkinson Disease 4, Autosomal Dominant Lewy Body 12Mesothelioma 12Carcinoma 11Head and Neck Neoplasms 10Breast Neoplasms 8Adenocarcinoma, Bronchiolo-Alveolar 7Small Cell Lung Carcinoma 6Ovarian Neoplasms 6Recurrence 5Pancreatic Neoplasms 4Colorectal Neoplasms 4Adenocarcinoma 4Triple Negative Breast Neoplasms 3Stomach Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 3Lung Diseases 3Laryngeal Diseases 3Carcinoma, Small Cell 3Brain Neoplasms 3Uterine Neoplasms 2Uterine Cervical Neoplasms 2Thoracic Neoplasms 2Solitary Fibrous Tumor, Pleural 2

Interventions

Cisplatin 4Cetuximab 4Pemetrexed 3N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 2Gemcitabine 2pembrolizumab 1monalizumab 1durvalumab 1X-Rays 1Vitamin B 12 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Proflavine 1Paclitaxel 1Modafinil 1Minocycline 1Metformin 1Gefitinib 1Gabapentin 1Folic Acid 1Fibroblast Growth Factor 7 1Drug Therapy 1Docetaxel 1Chemical Fractionation 1Carboplatin 1Bupropion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Laryngeal Diseases × Pemetrexed × Clear all
NCT01087970 2014-05-19

A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Eli Lilly and Company

Phase 2 Completed
69 enrolled 15 charts
Head & Neck

Head and Neck Neoplasms, Laryngeal Diseases

NCT00589667 2014-04-02

A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC)

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
26 enrolled 8 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Head and Neck Neoplasms, Laryngeal Diseases

NCT01057589 2013-09-18

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Eli Lilly and Company

Phase 2 Completed
66 enrolled 11 charts
Head & Neck

Head and Neck Neoplasms, Laryngeal Diseases, Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡